diabetes cat

Guidelines comparison table for T2D

Type 2 diabetes treatment pathway comparison


This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.

doctor & older man 1 260x173

Type 2 diabetes: frailty in older people


Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.


Pancreatic exocrine insufficiency guideline

2018-05-14T08:00:00+01:00By Development group: Hambling Cummings Merriman & Widdowson

This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.

diabetes equipment 640x426

SIGN type 2 diabetes guideline


This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm

View more summaries

Educational resources

20181214 Ozempic prescribing summary card cover half

Ozempic® ▼ (semaglutide) 1.34 mg/ml once‑weekly GLP-1 RA


Commissioned by Novo Nordisk Limited


Semaglutide 0.25 mg, 0.5 mg and 1 mg solution for injection in pre-filled pen (Ozempic®▼) SMC No. (2092)

2019-02-11T12:51:00+00:00Funded by Novo Nordisk Limited

Funded by Novo Nordisk Limited

Related Guidelines in Practice articles